CGAS and cancer: Furthermore, cGAS-DNA liquid condensates may represent another barrier to modulating the cellular efficacy of cGAS inhibitors, since liquid-liquid phase separation has been emerging as a novel mechanism of understanding the pharmacodynamics for cancer therapeutics65–67.